News
In Pictures: UCL among four top universities bringing inventors and industry together at IP4U
Industry specialists from across the continent came together to discover new technologies from four of the UK’s leading universities.
Enabling innovation for a better world
UCLB is the commercialisation company of UCL. We bring to market truly world-leading, world-changing technologies and innovations developed at UCL that have a real and positive impact on people’s lives.
Read more
Spinout News
UCL backed tumour-busting cancer therapy cleared for clinical trials
A tumour-busting drug developed at UCL in London, which scientists say could improve the current “dismal outlook” for people with pancreatic cancer, is set to be trialled in patients following U.S regulatory approval.
Listen to our podcast
UCLB - Big Talks on Big Impacts
Episode 9: HeLP-Diabetes: From early-stage social venture to national roll-out
In the ninth episode of this podcast series, Ana Lemmo Charnalia, Senior Business Manager at UCLB, is in conversation with Orla O’Donnell , Divisional Manager at the UCL Div of Biosciences and former Chief Operating Officer of HeLP Digital CIC, a Community Interest Company incorporated in 2015 to commercialise HeLP-Diabetes.
Events
I/O Lab
I/O Lab is a programme specifically designed for UCL academics interested in understanding how to assess the potential of their research in a commercialisation context. I/O Lab runs once a year and is delivered over two months (via in-person weekly sessions) by UCL Business together with the UCL Technology Fund.
1 /5